Therapeutics – MicroVibeNews

星期一, 1月 26, 2026

Viridian Therapeutics: Cautious Optimism As Key Milestones Approach (Rating Downgrade)

Viridian Therape…

TG Therapeutics: The "Exit Velocity" You Can't Ignore (Rating Upgrade)

TG Therapeutics:…

Lexeo Therapeutics, Inc. (LXEO) Presents at 44th Annual J.P. Morgan Healthcare Conference – Slideshow

Lexeo Therapeuti…

Denali Therapeutics Inc. (DNLI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Denali Therapeut…

Protagonist Therapeutics, Inc. (PTGX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Protagonist Ther…

Nurix Therapeutics, Inc. (NRIX) Presents at 44th Annual J.P. Morgan Healthcare Conference – Slideshow

Nurix Therapeuti…

Nurix Therapeutics, Inc. (NRIX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Nurix Therapeuti…

Jasper Therapeutics, Inc. (JSPR) Discusses Updated Data from BEACON and Open-Label Extension Studies in Chronic Urticaria – Slideshow

Jasper Therapeut…

Aquestive Therapeutics: Looking For The PDUFA Run-Up

Aquestive Therap…

Why Corcept Therapeutics’ Relacorilant Fell Short And What It Means For The Company

This article was…

Neumora Therapeutics, Inc. (NMRA) Discusses Positive Phase 1b Results for NMRA-511 in Alzheimer's Disease Agitation – Slideshow

Neumora Therapeu…

Viking Therapeutics: The Obesity Drugs Gold Rush Is Far From Over

Viking Therapeut…

Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains

Galectin Therape…

Nektar Therapeutics (NKTR) Discusses Topline Results From REZOLVE-AA Phase 2b Study of rezpegaldesleukin in Alopecia Areata – Slideshow

Nektar Therapeut…

Kyverna Therapeutics: "Strong Buy" Rating As Positive SPS Data Leads To 1st Half 2026 BLA Filing

Kyverna Therapeu…

Lexeo Therapeutics, Inc. (LXEO) Clinician Perspectives on Holistic Management of PKP2-Associated Arrhythmogenic Cardiomyopathy Transcript

Lexeo Therapeuti…

Cullinan Therapeutics, Inc. (CGEM) Discusses Initial CLN-049 Results and Development Strategy for AML Applications Transcript

Cullinan Therape…